West Pharmaceutical
635 hedge funds and large institutions have $16.2B invested in West Pharmaceutical in 2022 Q4 according to their latest regulatory filings, with 88 funds opening new positions, 231 increasing their positions, 231 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
4% less capital invested
Capital invested by funds: $16.9B → $16.2B (-$686M)
4% less call options, than puts
Call options by funds: $29.8M | Put options by funds: $31.2M
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
635
Holding in Top 10
5
Calls
$29.8M
Puts
$31.2M
Top Buyers
| 1 | +$437M | |
| 2 | +$108M | |
| 3 | +$92.5M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$87.2M |
| 5 |
Two Sigma Investments
New York
|
+$77.9M |
Top Sellers
| 1 | -$369M | |
| 2 | -$311M | |
| 3 | -$122M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$79.3M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$49.7M |